Talk:Vidarabine

This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Pharmacology Mid‑importance This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles Mid This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Vidarabine. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC

The reference "McGuigan, C. Antiviral Chemotherapy – Cardiff University, 3rd Year Pharmacy Notes Lecture Notes." is not a

These sentences: "This is where ara-ATP is incorporated into the DNA strand replacing many of the adenosine bases. This results in the prevention of DNA synthesis, as phosphodiester bridges can longer to be built, destabilizing the strand.", especially the last part, is unclear and not very meaningful - if an ara base is incorporated, does that result in the DNA polymerase no longer recognizing the growing strand as a substrate, and therefore lead to strand termination? --Christina Jacobs, 68.80.179.147 (talk) 13:17, 11 August 2008 (UTC)[reply]

Is it really more toxic than Gancyclovir? At the end of the article, it says that side effects are rare and in most cases only occur after high doses. In Gancyclovir, side effects are not so rare. Chaptagai (talk) 22:48, 9 October 2017 (UTC)[reply]